|
× |
 |
Summary of Findings From the FDA Regulatory Science Forum on Measuring Sexual Dysfunction in Depression Trials PDF |
$40.00 |
|
$40.00 |
|
× |
|
Agitation Management During the COVID-19 Pandemic: The Time for a Noncoercive Approach Is Now PDF |
$40.00 |
|
$40.00 |
|
× |
|
Low-Dose Lorazepam in the Treatment of Catatonia PDF |
$40.00 |
|
$40.00 |
|
× |
|
Clozapine Withdrawal-Emergent Dystonias and Dyskinesias: A Case Series PDF |
$40.00 |
|
$40.00 |
|
× |
|
Polymorphisms and Haplotypes in the YWHAE Gene Increase Susceptibility to Bipolar Disorder in Chinese Han Population PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Transdermal Delivery System of Monoamine Oxidase Inhibitors PDF |
$40.00 |
|
$40.00 |
|
× |
|
Multiple Genetic Factors in Olanzapine-Induced Weight Gain in Schizophrenia Patients: A Cohort Study PDF |
$40.00 |
|
$40.00 |
|
|
